GlobalData on MSN5 天
Melt reports topline outcomes from trial of MELT-300 for cataract surgery
Melt Pharmaceuticals has reported encouraging topline results from its Phase III trial of MELT-300, a non-intravenous, ...
ophthalmologytimes7 天
Melt Pharmaceuticals reports positive Phase 3 topline efficacy results for MELT-300
This technology allows the tablet to dissolve in as little as 3 seconds, enabling absorption of the active ingredients across ...